Atea Pharmaceuticals Inc (AVIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 41,569 | 39,899 | 16,281 | 32,295 | 42,175 |
| Operating Income | -41,569 | -39,899 | -16,281 | -32,295 | -42,175 |
| Other Income | 6,299 | 5,591 | 4,382 | 1,080 | 98 |
| Pre-tax Income | -35,270 | -34,308 | -11,899 | -31,215 | -42,077 |
| Income Tax | 197 | 123 | -3,833 | 120 | N/A |
| Net Income Continuous | -35,467 | -34,431 | -8,066 | -31,335 | -42,077 |
| Net Income | $-35,467 | $-34,431 | $-8,066 | $-31,335 | $-42,077 |
| EPS Basic Total Ops | -0.43 | -0.40 | -0.10 | -0.38 | -0.51 |
| EPS Basic Continuous Ops | -0.43 | -0.41 | -0.10 | -0.38 | -0.51 |
| EPS Diluted Total Ops | -0.43 | -0.40 | -0.10 | -0.38 | -0.51 |
| EPS Diluted Continuous Ops | -0.43 | -0.41 | -0.10 | -0.38 | -0.51 |
| EBITDA(a) | $-44,552 | $-42,795 | $-18,640 | $-32,252 | $-42,168 |